TET2 and myelodysplastic syndrome: Thus, TET2 protein has been implicated in the development of hematological malignancies such as acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and Myelodysplastic syndrome (MDS) (Tefferi et al., 2009).